The administration of phage therapy for aquaculture disease has been anticipated by the researchers over a decade as an effective and an alternative control mechanism, though the application of phages as a disease control agent in aquaculture projects various beneficial aspects, critical limitations, and negative influence on production. This present scenario made a pressure to review the possible disclosure of phage therapy with its critical boundaries and limiting influences towards the disease control management of aquaculture (fish, shrimps, lobsters, bivalve mollusks, etc.). The phage therapy has proven its efficacy as a biocontrol agent towards aquaculture disease, although the sustainability of the phage therapy needs further investigation on the following: commercial application, formulation of bacteriophage for layman usage, and development of protocol for various diseases with consistent results. The marginal space existing between the inventors and the end user must be fulfilled by the awareness program and the government policies. The administration of the phage therapy could be effective for long-term safety and negatively influence the development of multidrug-resistant bacteria pathogens in the future.

研究人员已经预见了十年来，研究人员预计将噬菌体疗法用于水产养殖疾病是一种有效的替代控制机制，尽管在水产养殖中将噬菌体作为疾病控制剂的应用具有多种有益方面，关键局限性以及对水产养殖业的负面影响。生产。目前的情况迫使审查具有可能的噬菌体治疗方法的关键界限，并限制了对水产养殖疾病控制管理的影响（鱼，虾，龙虾，双壳软体动物等）。尽管噬菌体疗法的可持续性需要在以下方面进行进一步研究，但已证明噬菌体疗法可以作为针对水产养殖疾病的生物防治剂：商业应用，为外行使用的噬菌体配方，并开发出具有一致结果的各种疾病方案。发明者计划和政府政策必须满足发明人和最终用户之间存在的边际空间。噬菌体疗法的实施对于长期安全性可能是有效的，并且将来会对多药耐药细菌病原体的发展产生负面影响。